Gritstone bio, Inc. (GRTS)
Gritstone bio has a market cap or net worth of $787.30 million. The enterprise value is $598.24 million.
The latest earnings date was Thursday, November 4, 2021 before market open.
|Last Earnings Date||Nov 4, 2021|
Gritstone bio has 67.99 million shares outstanding. The number of shares has increased by 106.03% in one year.
|Shares Change (YoY)||+106.03%|
|Shares Change (QoQ)||+1.34%|
|Owned by Insiders (%)||3.38%|
|Owned by Institutions (%)||62.90%|
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.
|EV / Earnings||n/a|
|EV / Sales||12.87|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 6.01, with a Debt / Equity ratio of 0.13.
|Debt / Equity||0.13|
|Debt / EBITDA||-0.47|
|Debt / FCF||-0.48|
|Return on Equity (ROE)||-38.50%|
|Return on Assets (ROA)||-30.10%|
|Return on Capital (ROIC)||-62.50%|
|Revenue Per Employee||$247,335|
|Profits Per Employee||-$385,532|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +284.35% in the last 52 weeks. The beta is 0.06, so Gritstone bio's price volatility has been lower than the market average.
|52-Week Price Change||+284.35%|
|50-Day Moving Average||10.71|
|200-Day Moving Average||9.61|
|Average Volume (30 Days)||1,238,458|
Short Selling Information
|Short % of Shares Out||2.58%|
|Short % of Float||3.89%|
|Short Ratio (days to cover)||1.76|
In the last 12 months, Gritstone bio had revenue of $46.50 million and -$72.48 million in losses. Earnings per share was -$1.07.
|Earnings Per Share (EPS)||-$1.07|
The company has $216.36 million in cash and $27.30 million in debt, giving a net cash position of $189.06 million or $2.78 per share.
|Cash & Cash Equivalents||216.36M|
|Net Cash Per Share||$2.78|
|Book Value Per Share||3.06|
In the last 12 months, operating cash flow was -$52.12 million and capital expenditures -$4.41 million, giving a free cash flow of -$56.52 million.
|Operating Cash Flow||-52.12M|
|Free Cash Flow||-56.52M|
|FCF Per Share||-$0.83|
Gross margin is 100.00%, with operating and profit margins of -156.07% and -155.87%.
Dividends & Yields
Gritstone bio does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|